Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae

Clinical Infectious Diseases

Volumn 35, Issue 5, 2002, Pages 556-564

  Lonks, John R ^a   Garau, Javier ^b   Gomez, Lucía ^b   Xercavins, Mariona ^b   Ochoa de Echagüen, Anna ^b   Gareen, Ilana F ^c   Reiss, Philip T ^c   Medeiros, Antone A ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; MACROLIDE; METHYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CHILD; CROSS RESISTANCE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; ERYTHROMYCIN; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

EID: 0036720521     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/341978     Document Type: Article

References (36)

1. Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention
2. Practice guidelines for the management of community-acquired pneumonia in adults
3. Management of community-acquired pneumonia in the era of pneumococcal resistance: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
4. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
5. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: A 6-year population-based assessment
6. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain (1979-1997)
7. Resistant pneumococci: A renewed threat in respiratory infections
8. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modifcation
9. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: A common resistance pattern mediated by an efflux system
10. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America
11. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms
12. Macrolide resistance among invasive Streptococcus pneumoniae isolates
13. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995
14. Infections caused by erythromycin-resistant Streptococcus pneumoniae: Incidence, risk factors, and response to therapy in a prospective study
15. Pneumococcal macrolide resistance - Myth or reality?
16. Reply
17. Empirical therapy of community-acquired pneumonia: Macrolides are not ideal choices
18. Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host
19. High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R. I
20. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin
21. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin
22. Pneumococcal meningitis during therapy of otitis media with clarithromycin
23. Breakthrough sepsis in macrolide-resistant pneumococcal infection
24. Bacteremic and non-bacteremic pneumococcal pneumonia: A prospective study
25. Detection of erythromycin-resistant determinants by PCR
26. Matched case-control studies with a variable number of controls per case
27. Adult patients with occult bacteremia discharged from the emergency department: Epidemiological and clinical characteristics
28. Effects of carbon dioxide upon the in vitro activity of erythromycin
29. Efficacies of ABT-773, a new ketolide, against experimental bacterial infections
30. Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy
31. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta
32. Mortality, from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997
33. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia
34. Community-acquired pneumonia guidelines - An international comparison: A view from Europe